Clinical Trial Update: Cisplatin in Castration Resistant Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial update reports on the use of cisplatin for castration-resistant prostate cancer, noting the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: University of Rochester | Conditions: Prostate Cancer | EARLY_Phase 1 | Status: COMPLETED